140 related articles for article (PubMed ID: 20472432)
1. Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method.
Kowalski JA; Swinamer AD; Muegge I; Eldrup AB; Kukulka A; Cywin CL; De Lombaert S
Bioorg Med Chem Lett; 2010 Jun; 20(12):3703-7. PubMed ID: 20472432
[TBL] [Abstract][Full Text] [Related]
2. Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.
Hwang SH; Morisseau C; Do Z; Hammock BD
Bioorg Med Chem Lett; 2006 Nov; 16(22):5773-7. PubMed ID: 16949285
[TBL] [Abstract][Full Text] [Related]
3. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
Anandan SK; Gless RD
Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
[TBL] [Abstract][Full Text] [Related]
4. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening.
Xing L; McDonald JJ; Kolodziej SA; Kurumbail RG; Williams JM; Warren CJ; O'Neal JM; Skepner JE; Roberds SL
J Med Chem; 2011 Mar; 54(5):1211-22. PubMed ID: 21302953
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.
Kim IH; Morisseau C; Watanabe T; Hammock BD
J Med Chem; 2004 Apr; 47(8):2110-22. PubMed ID: 15056008
[TBL] [Abstract][Full Text] [Related]
7. Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors.
Anandan SK; Do ZN; Webb HK; Patel DV; Gless RD
Bioorg Med Chem Lett; 2009 Feb; 19(4):1066-70. PubMed ID: 19168352
[TBL] [Abstract][Full Text] [Related]
8. Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors.
Shen HC; Ding FX; Wang S; Xu S; Chen HS; Tong X; Tong V; Mitra K; Kumar S; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Chen X; Zhang B; Tata JR; Berger JP; Colletti SL
Bioorg Med Chem Lett; 2009 Jul; 19(13):3398-404. PubMed ID: 19481932
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.
Shen HC; Ding FX; Deng Q; Xu S; Chen HS; Tong X; Tong V; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Zhang B; Roy S; Tata JR; Berger JP; Colletti SL
Bioorg Med Chem Lett; 2009 Sep; 19(18):5314-20. PubMed ID: 19682899
[TBL] [Abstract][Full Text] [Related]
10. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.
Taylor SJ; Soleymanzadeh F; Eldrup AB; Farrow NA; Muegge I; Kukulka A; Kabcenell AK; De Lombaert S
Bioorg Med Chem Lett; 2009 Oct; 19(20):5864-8. PubMed ID: 19758802
[TBL] [Abstract][Full Text] [Related]
12. Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase.
Xing L; Goulet R; Johnson K
J Chem Inf Model; 2011 Jul; 51(7):1582-92. PubMed ID: 21615155
[TBL] [Abstract][Full Text] [Related]
13. The structure-activity relationship of urea derivatives as anti-tuberculosis agents.
Brown JR; North EJ; Hurdle JG; Morisseau C; Scarborough JS; Sun D; Korduláková J; Scherman MS; Jones V; Grzegorzewicz A; Crew RM; Jackson M; McNeil MR; Lee RE
Bioorg Med Chem; 2011 Sep; 19(18):5585-95. PubMed ID: 21840723
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
[TBL] [Abstract][Full Text] [Related]
15. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase.
Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ
Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862
[TBL] [Abstract][Full Text] [Related]
16. Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.
Anandan SK; Webb HK; Do ZN; Gless RD
Bioorg Med Chem Lett; 2009 Aug; 19(15):4259-63. PubMed ID: 19520575
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement.
Shen HC; Ding FX; Wang S; Deng Q; Zhang X; Chen Y; Zhou G; Xu S; Chen HS; Tong X; Tong V; Mitra K; Kumar S; Tsai C; Stevenson AS; Pai LY; Alonso-Galicia M; Chen X; Soisson SM; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
J Med Chem; 2009 Aug; 52(16):5009-12. PubMed ID: 19645482
[TBL] [Abstract][Full Text] [Related]
18. Traceless solid-phase synthesis of 2,4,6-trisubstituted thiazolo[4,5-d]pyrimidine-5,7-dione derivatives.
Lee T; Park JH; Lee DH; Gong YD
J Comb Chem; 2009; 11(3):495-9. PubMed ID: 19338271
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
[TBL] [Abstract][Full Text] [Related]
20. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
